Malakoff Humanis company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

malakoffhumanis.com

Founded Year

2020

About Malakoff Humanis

Malakoff Humanis is an insurance company offering consultations and services for healthcare, retirement, pensions, financials and more.

Malakoff Humanis Headquarter Location

21, Rue Laffitte

Villennes-sur-Seine, 75009,

France

00 33 9 69 32 3932

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Malakoff Humanis News

Cegedim : Growth picked up speed in Q2 2022

Jul 28, 2022

July 28, 2022 11:45 ET IFRS - Regulated information - Not audited Cegedim: Growth picked up speed in the second quarter of 2022 Q2 2022 revenues grew 7.5% All operating divisions contributed to growth H1 2022 revenues grew 6.5% Cegedim Santé: €65 million reserved capital increase completed H1 recurring operating income(3) expected to be down Boulogne-Billancourt, France, July 28, 2022, after the market close Consolidated second quarter revenues rose 7.5% as reported and 7.0% like for like(1) compared with the same period in 2021. First half revenues rose 6.5% as reported and 6.1% like for like(1) compared with the same period in 2021. This shows that the second quarter was particularly dynamic. Laurent Labrune, Deputy Managing Director of Cegedim, said: “Growth picked up speed in the second quarter and all operating divisions contributed, which demonstrates that our strategy is sound. A lot happened this past quarter. We acquired Mesdocteurs, a leader in telehealth and a pioneer in 24/7 telemedicine; Laponi, an innovative solution for managing absenteeism in real time; and Sedia, tracking software for medical instrumentation since 1985. We launched a groundbreaking strategic industrial partnership between Cegedim Santé and three social protection companies whose services cover 25 million beneficiaries in France and carried out a €65 million reserved capital increase for Cegedim Santé. We are entering the second half of the year with confidence as we look to take full advantage of trends in the markets where we are present, and we continue to invest in innovation and our sales force.” Revenue (1)   At constant scope and exchange rates. (2)   The positive currency impact of 0.2% was mainly due to the pound sterling. The positive scope effect of 0.2% was attributable to the first-time consolidation at June 30, 2021, of Kobus Tech and at June 30, 2022, of Mesdocteurs. (3)   See 2021 Universal Registration Document Chapter 4 “Consolidated Financial Statements” section 4.6 Note 2 on Alternative performance indicators. Analysis of business trends by division Software & Services H1 2022 division revenues came to €145.6 million, up 3.0% like for like(1) compared with the same period in 2021. All of the division’s activities turned in solid performances with the exception of the still-recovering healthcare professional computerization business in the UK. Flow H1 2022 division revenues came to €45.2 million, up 8.2% like for like(1) compared with the same period in 2021. The process digitalization and digital data flow business experienced strong growth in France. The clear recovery seen in Germany and the UK in the first quarter continued in the second. The healthcare flow business related to healthcare reimbursements in France also grew over the first half. Data & Marketing H1 2022 division revenues came to €50.0 million, up 11.8% like for like(1) compared with the same period in 2021. Data and digital communication solutions for French pharmacies still have good momentum. BPO H1 2022 division revenues came to €25.4 million, up 10.8% like for like(1) compared with the same period in 2021. The business of providing services for insurance companies and mutual insurance providers was stable in the first quarter and posted double-digit growth in the second quarter. Growth in BPO services for HR departments--already in double digits in Q1--ramped up in the second quarter. Corporate and others H1 2022 division revenues came to €1.3 million, down 11.2% like for like(1) compared with the same period in 2021. Highlights Apart from the items cited below, to the best of the company’s knowledge. there were no events or changes during Q2 2022 that would materially alter the Group’s financial situation. War in Ukraine The Group does not do business in Russia or Ukraine and has no assets exposed to those countries. Groundbreaking strategic industrial partnership between Cegedim and Malakoff Humanis, Groupe VYV, and PRO BTP On May 16, 2022, Cegedim Group and social protection companies Malakoff Humanis, Groupe VYV, and PRO BTP Groupe announced that they had finalized the strategic partnership they began negotiating on March 1, 2022. This strategic partnership will advance the goals laid out by the French government in its Ma Santé 2022 plan. It will draw on the recognized expertise of Cegedim, Malakoff Humanis, Groupe VYV, and PRO BTP, all of whom share the goal of improving patients’ access to care and making the course of care as smooth as possible. To this end, Malakoff Humanis, Groupe VYV, and PRO BTP Groupe—who together represent 25 million beneficiaries in France—subscribed a reserved capital increase of €65 million on May 25, 2022, and now own 8% of the shares of Cegedim Santé. The deal values Cegedim Santé at €360.9 million. As part of the deal, Cegedim Santé acquired Groupe VYV subsidiary MesDocteurs, a telehealth solution pioneer and one of the originators of 24/7 telemedicine. ------------------ Acquisition of Laponi On June 21, 2022, Cegedim SRH acquired Laponi, an innovative solution for managing absenteeism in real time. Laponi, a French startup founded in 2016, has successfully developed a digital SaaS platform that lets companies ask internal and external employees to cover shifts when someone is absent. The Laponi solution is easy to use and alerts employees in real time about tasks that need to be done. Employees are then free to choose tasks while boosting their income. The acquisition enhances Cegedim SRH’s TeamsRH HRIS platform. As a standalone component in Cegedim SRH’s portfolio, Laponi will be able to help solve absenteeism issues at the company’s 400 clients, and its solution will benefit from Cegedim SRH’s technical and financial resources as well as its sales force. Laponi is profitable. It began contributing to the Group’s consolidation scope on July 1, 2022. Significant transactions and events post June 30, 2022 Apart from the item cited below, to the best of the company’s knowledge, there were no post-closing events or changes after June 30, 2022, that would materially alter the Group’s financial situation. Acquisition of Sedia On July 19, 2022, Cegedim e-business rounded out its Hospitalis offering by acquiring Sedia. Sedia has specialized in software that tracks medical instrumentation usage since 1985. Thanks to this acquisition, Hospitalis now offers a medical device and implantable medical device (MD/IMD) tracking service. The service is responsible for 900,000 scans annually and has tracked more than 8 million IMDs. The newest component in the Hospitalis range, Sedia offers health, financial, and logistical tracking of MD/IMDs that are on consignment or have been lent or purchased outright. Sedia is profitable. It will begin contributing to the Group’s consolidation scope on August 1, 2022. Outlook Based on H1 2022 revenues up 6.1% like for like(1), and despite the public health, economic, geopolitical, and monetary uncertainty facing the world, the Group is confident it can grow revenues by 5% like for like(1) in 2022. There is a delay of several months between wage increases and the annual increase in product prices resulting from indexation, for example products linked to the Syntec index in France. The negative impact of that delay, combined with continued investment in R&D and the sales force, will be a headwind for H1 recurring operating income(2). WEBCAST ON JULY 28, 2022, AT 6:15 PM (PARIS TIME) The webcast is available at: www.cegedim.fr/webcast   (1)   At constant scope and exchange rates. (2)   See 2021 Universal Registration Document Chapter 4 “Consolidated Financial Statements” section 4.6 Note 2 on Alternative performance indicators. Disclaimer This press release is available in French and in English. In the event of any difference between the two versions, the original French version takes precedence. This press release may contain inside information. It was sent to Cegedim’s authorized distributor on July 28, 2022, no earlier than 5:45 pm Paris time. The figures cited in this press release include guidance on Cegedim's future financial performance targets. This forward-looking information is based on the opinions and assumptions of the Group’s senior management at the time this press release is issued and naturally entails risks and uncertainty. For more information on the risks facing Cegedim, please refer to Chapter 7, “Risk management”, section 7.2, “Risk factors and insurance”, and Chapter 3, “Overview of the financial year”, section 3.6, “Outlook”, of the 2021 Universal Registration Document filled with the AMF on April 1st, 2022, under number D.22-0232.

Malakoff Humanis Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Malakoff Humanis Rank

  • When was Malakoff Humanis founded?

    Malakoff Humanis was founded in 2020.

  • Where is Malakoff Humanis's headquarters?

    Malakoff Humanis's headquarters is located at 21, Rue Laffitte, Villennes-sur-Seine.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.